Mark Enyedy

(Mr. Mark Enyedy J.D.)

Currently holds positions in LogicBio Therapeutics Inc, Akebia Therapeutics Inc and ImmunoGen Inc

Positions

Position Company Period
Director LogicBio Therapeutics Inc March 17, 2020 -
Independent Director Akebia Therapeutics Inc Dec. 12, 2018 -
President, Chief Executive Officer, Director ImmunoGen Inc May 16, 2016 -
Independent Director Keryx Biopharmaceuticals Inc Sept. 11, 2017 - Dec. 12, 2018
Independent Director Fate Therapeutics Inc July 1, 2012 - May 2, 2018
Director Proteostasis Therapeutics Inc June 30, 2014 - Jan. 1, 2015
Chief Executive Officer, Director Proteostasis Therapeutics Inc None -
Mark Enyedy's trades of ImmunoGen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-06 2024-02-05
US ImmunoGen Inc (IMGN)
PS Planned sale
20,107 -3.3%
29.28
USD 588,733 		20,107 -3.3% 29.28 USD 588,733
2023-08-04 2023-08-04
US ImmunoGen Inc (IMGN)
S Sale
992,397 -64.2%
16.96
USD 16,831,053 		992,397 -64.2% 16.96 USD 16,831,053
2023-08-04 2023-08-03
US ImmunoGen Inc (IMGN)
S Sale
1,020,000 -69.8%
16.61
USD 16,942,200 		1,020,000 -69.8% 16.61 USD 16,942,200
2023-08-04 2023-08-02
US ImmunoGen Inc (IMGN)
S Sale
8,636 -1.9%
18.15
USD 156,743 		8,636 -1.9% 18.15 USD 156,743
2023-08-04 2023-08-02
US ImmunoGen Inc (IMGN)
S Sale
986,521 -68.7%
17.45
USD 17,214,791 		986,521 -68.7% 17.45 USD 17,214,791
2020-02-25 2020-02-24
US ImmunoGen Inc (IMGN)
PS Planned sale
55,222 -11.3%
4.99
USD 275,558 		55,222 -11.3% 4.99 USD 275,558
2019-02-25 2018-02-22
US ImmunoGen Inc (IMGN)
PS Planned sale
51,070 -9.5%
5.60
USD 285,992 		51,070 -9.5% 5.60 USD 285,992
// ... existing code ... // ... rest of the file ...